The aim of this study was to investigate whether the previously observed adaptive changes in the monoaminergic receptors in post-mortem brains of depressed suicide victims are associated with alteration in some functional proteins involved in serotonergic neuronal signalling, namely PKC and GAP-43. Selected regions from ten brains of antidepressant-free depressed suicide victims and ten matched controls were used to examine the levels of GAP-43 protein, GAP-43 mRNA and PKC isoenzymes by Western blotting with monoclonal antibodies specific for these proteins. A major finding of the study was a significant decrease in GAP-43 protein levels and its mRNA expression in prefrontal cortex (BA9) (by 24% and 34%, respectively) of suicide brains compared to controls. No significant changes were found in GAP-43 protein or its mRNA in frontopolar cortex (BA10), amygdala, substantia nigra or putamen. Levels of PKC isoenzymes had a heterogenous regional distribution but were not significantly altered in any of the regions examined. Given the role of GAP-43 in the establishment and reorganization of synaptic connections, the finding of selective reduction of this protein in prefrontal cortex suggests that a dysfunctional synaptic organization in this region may be associated with depression and suicidal behaviour. This study provides the first evidence of an alteration in a protein related to the neuronal plasticity in the brain of depressed suicide victims.
Introduction
Evidence indicates that an increased density of 5-HT 2A receptors is present in the brain (namely in prefrontal cortex, BA9 and in amygdala) of depressed suicide victims. 1, 2 The mechanism of this 5-HT 2A receptor upregulation is unknown. It may represent a compensatory effort to overcome a decreased efficiency of serotonergic transmission as demonstrated by the decrease in presynaptic serotonin nerve terminals labelled by serotonin transporter binding. 3 Alterations of noradrenergic and dopaminergic receptors have also been reported in the prefrontal cortex of suicide victims, [4] [5] [6] suggesting that a general adaptive phenomenon is occurring in this brain region of depressives with suicidal behaviour. Furthermore, a decreased activity, as determined by regional blood flow and glucose metabolism, has also been observed in prefrontal cortex of patients with depressive illness. 7, 8 This decrement in activity was partly explained by a corresponding reduction in cortical volume. 8 Studies on the molecular mechanisms of neuroplasticity have identified protein kinase C (PKC) and its substrate GAP-43 as important elements of this phenomenon. Changes in the expression of this protein have been correlated to functional plasticity occuring during long-term potentiation 9 as well as to structural remodelling occurring following brain lesion. 10, 11 Of several PKC isoforms, the ␣, ␤, ␥, ␦, ⑀ and isoenzymes have been identified in the brain and some show an exclusive (␥) or predominant (⑀) localization in nervous tissue. 12 In human brain, reduced levels of the ␤II isoform were found in victims of Alzheimer's and Huntington's disease. 13, 14 The neuron-specific GAP-43 protein is a major substrate for phosphorylation by PKC. This protein which plays an important role in neuritic outgrowth during the development has been demonstrated to be involved in the structural and functional plasticity of mature brain. 15 We have previously shown that GAP-43 mRNA is highly expressed in monoaminergic neurons of adult rat brain 16 and phosphorylation of this protein has been linked to monoamine release. [17] [18] [19] We also found a high expression of GAP-43 mRNA in the limbic system of the adult rat including the amygdala and neo-cortex. 20 Similarly, in human brain, the transcript of GAP-43 is enriched in the cortex and limbic system. 21 Recently, increased levels of GAP-43 were found in visual, associative and frontal cortices of schizophrenic brain. 22, 23 In the present study, we have investigated whether the reported changes in monoaminergic function in the brain cortical and limbic regions of suicide victims may be associated with an alteration in the levels of various PKC isoenzymes or GAP-43 protein and its mRNA.
Materials and methods
Brains from suicide victims and from subjects who died suddenly from causes not directly involving the central nervous system (CNS) and without documented evidence of mental illness (controls) were obtained at autopsy at the Department of Forensic Medicine of the Semmelweis University Medical School in Budapest. The medical, psychiatric and drug history of suicide victims was obtained by 'psychological autopsy' including interviews with the attending physician or psychiatrist, family members and relatives, and from medical or hospital records. Subjects with a history of schizophrenia, epilepsy, alcohol abuse or other drug abuse were excluded from this study. In 15 cases, a psychiatric diagnosis of affective disorder was on record. These included diagnoses of recurrent major depression-unipolar, bipolar illness-depressed phase, depression with psychotic features and schizoaffective disorder, that had been established by experienced psychiatrists on the basis of DSM-IIIR and DSM-IV criteria. Out of these 15 cases, 10 subjects, as far as could be determined by 'psychological autopsy' and medical records, did not use antidepressant medication for at least 2 months prior to death and did not have a history of drug or alcohol abuse. These were selected for the present study and matched with 10 control cases for age, gender and post-mortem delay as much as possible. Seven of the depressed suicide victims had a diagnosis of major depression-unipolar, two of bipolar illness-depressive phase and one of depression with psychotic features. Suicide victims died by hanging (n = 8) or sedative drug overdose (n = 2). Toxicological tests on blood samples did not reveal the presence of drugs or alcohol in cases of death by hanging. Causes of death in control subjects were acute heart failure (n = 6) and acute myocardial infarction (n = 4). None of these subjects had a history of psychiatric illness or drug and alcohol abuse. There were seven males and three females in each group. Demographic details, psychiatric diagnosis and cause of death for all subjects are reported in Table 1 .
Tissue collection, dissection and storage
Brains were obtained at 1-12 h after death at the autopsy in the Department of Forensic Medicine, Semmelweis University Medical School. The post-mortem delay for control brains was significantly shorter than that of brains of suicide victims (Table 1) . After removal from the skull for rapid freezing, the brains were cut into six major pieces (four cortical lobes, basal ganglia-diencephalon and lower brain stemcerebellum), frozen on dry ice and stored at −70°C until dissection (2 days to 2 months). At the time of dissection, the brain samples were sliced in 1-1.5 mm thick coronal sections. Three brain regions: amygdala (containing all of the amygdaloid nuclei except the amygdaloid cortex), substantia nigra and putamen were dissected by punch technique 24, 25 while the cortical samples were cut out of the sections by a fine microdissecting (Graefe's) knife. The prefrontal cortex (Brodmann area 9) was taken from the most polar portion of the superior and partly from the middle superior gyrus between the superior and intermediate frontal sulci. The frontopolar cortex (Brodmann area 10) was dissected just ventral to the prefrontal cortex at the most polar portion of the frontal lobe below the intermediate frontal sulcus. Cortical samples were always taken from the right hemisphere, while micropunches were bilateral. The samples were stored in air-tight containers or plastic tubes at −70°C until further use. Samples of some regions were only available from six or eight suicide brains. They were matched with appropriate control cases.
GAP-43 protein and PKC isoenzyme determination
Preparation of synaptosomal membranes Synaptosomal membranes were prepared as described earlier. 26 Frozen tissue samples were homogenized in 10 volumes of ice-cold homogenizing buffer (0.32 M sucrose, 5 mM benzamidine, 2 mM dithiothreitol, 3 mM EGTA, 0.5 mM MgSO 4 , 0.5 mM ZnSO 4 , 0.1 mM phenylmethylsulphonyl fluoride, 0.1 mg ml −1 leupepsin, 0.05 mg ml −1 pepstatin and 0.1 mg ml −1 aprotinin) for 15 s in a Polytron homogenizer (setting 6). The homogenate was centrifuged at 10 000 × g and 4°C for 15 min. The resulting supernatant was then centrifuged at 100 000 × g and 4°C for 1 h. The pellet was rinsed with 200 l of ice-cold hypotonic buffer containing 1 mM Tris-HCl, pH 7.4; 5 mM MgCl 2 ; 0.1 mM CaCl 2 ; 1 mM phenylmethylsulphonylfluoride and 0.1 mg ml −1 leupeptin, and then resuspended on ice in 700 l of the same buffer in order to lyse the synaptosomal vesicles. 27 The lysate was then centrifuged at 100 000 × g for 30 min. The pellet was suspended in the homogenizing buffer and used for further analyses.
SDS-PAGE, Western immunoblotting and autoradiography
The membrane proteins were resolved on 10% polyacrylamide gels with a mini-PROTEAN gel system (Bio-Rad Laboratories Ltd, Cambridge, MA, USA). 28 The same amount of protein sample was applied in all experiments. Molecular weight standards (Bio-Rad) were run in parallel with samples. The membrane proteins separated by SDS-PAGE were electrophoretically transferred to nitrocellulose membrane and immunoblotted. 28 After blocking the non-specific binding with 5% skimmed milk powder, the blots were incubated overnight at 4°C with respective (anti-GAP- 43, anti-PKC␣, ␤, ␥ and ⑀) monoclonal antibodies (Transduction Laboratory, Lexington, Kentucky, KY, USA) and then incubated for 1 h at room temperature with a secondary antibody (rabbit antimouse IgG) linked to horseradish peroxidase. The antibody binding was visualized by an enhanced chemiluminescent (ECL) detection system and the relative band densities were measured by densitometry using MCID 29 and expressed as relative optical density (ROD). There was a linear relationship between the ROD and amount of synaptosomal membrane protein loaded on the gel within the range of 2-20 g for GAP-43 protein and 10-50 g for PKC isoenzymes. Membrane preparations from the same regions of control and suicide brains were run through the procedure side-by-side. Under our experimental conditions, the specific anti-GAP-43 antibody labelled, in human brain membranes, a single band of apparent MW of about 60 kD (Figure 1 ). Under different experimental conditions, GAP-43 exhibits molecular masses of between 43 and 67 kDa. We have shown previously 26 that the antibody labels the same band by immunoprecipitation in rat cerebrocortical synaptosomes. Monospecific antibodies against PKC isoenzymes ␣, ␤, ␥ and ⑀ recognized on the immunoblots single bands corresponding well to their reported molecular weights. 
Protein determination
Protein content of the synaptosomal membrane preparation was determined by Bradford's protein assay with bovine serum albumin as a standard.
GAP-43 mRNA determination
Total RNA was isolated from frozen brain tissue samples by using RNAzol B kit (Biotecx Laboratories, Houston, TX, USA). About 15 g of each RNA was then subjected to electrophoresis on 1.2% agarose formaldehyde gel and transferred to nylon membranes (GeneScreen-Plus, NEN, Boston, MA, USA). Some RNA samples appeared partially degraded as detected by the smear observed on the ethidium bromidestained gel. This resulted in widespread autoradiographic signals on the Northern blots with resulting high variability in the quantitative analysis. Therefore, another 15 g of each RNA were spotted in duplicate on nylon membranes using a slot-blot apparatus (Minifold II-Schleicher-Schuell, Germany). The membranes were prehybridized at 42°C in a solution containing 50% formamide, 1% sodium dodecylsulphate (SDS), 1 M NaCl, 10% dextran sulphate and 100 g ml −1 of denatured salmon sperm DNA. After 4 h, the 32 P-radiolabelled GAP-43 cDNA or ␤-actin cDNA probes (0.8-1.0 × 10 6 cpm l −1 were added to the prehybridization buffer and the membranes were incubated for 16-18 h at 42°C. The cDNA were labelled with [ 32 P]-dCTP using a Redi Prime KIT (Amersham, Little Chalfont, Bucks, UK). GAP-43 was a 0.7-kb fragment from a rat cDNA clone (clone GA11B 30 ) and ␤-actin was a 0.8-kb fragment from a human cDNA clone corresponding to the published sequence. 31 The ␤-actin mRNA levels were evaluated in each blot for normalizing the levels of GAP-43 mRNA. This strategy was applied to reduce the variability among samples due to possible differences in the amount of total RNA loaded on the gel and to partial RNA degradation in some samples. The blots were washed twice with 2 × SSC (0.3 M NaCl, 0.03 M sodium citrate) and 0.1% SDS at room temperature and then twice in 0.1 × SSC and 0.1% SDS at 65°C. The membranes were exposed to X-ray film at −80°C with intensifying screens for the time needed to acquire a signal in a linear range for quantification (1 week for GAP-43 mRNA and 2 days for ␤-actin mRNA). The autoradiograms were scanned and quantitated using a computerized image analysis system (IBAS, Kontron-Zeiss, Milan, Italy). 32 The signal associated with the presence of ␤-actin mRNA was used as internal standard to normalize the GAP-43 mRNA expression. The results are expressed as the ratio of GAP-43 mRNA and ␤-actin mRNA optical densities. Representative slot blots of GAP-43 and ␤-actin mRNAs are presented in Figure 2 .
Statistical analysis
Non-parametric statistics were used to evaluate the significance of variance or group differences in results. The regional differences in various parameters within the groups were examined by Kruskal-Wallis analysis of variance (ANOVA) by ranks. The differences Figure 2 Representative slot-blot of GAP-43 and ␤-actin mRNA from the prefrontal cortex (BA9) and frontopolar cortex (BA10) of a depressed suicide (S) and control (C) subject. Fifteen micrograms of total RNA were immobilized on nylon membranes. The filters were washed, hybridized with 32 P-GAP-43 cDNA probe and exposed to autoradiographic film. After removal of the GAP-43 cDNA probe the membranes were rehybridized with 32 P-␤-actin cDNA.
between the groups were determined by Mann-Whitney U-test (two-tailed). Analysis of covariance (ANCOVA) was used to evaluate the effect of concomitant variables (age and post-mortem delay) on group differences. The relationship between various neurochemical parameters and age or post-mortem delay was assessed by Spearman rank correlation. The level of significance was defined as P Ͻ 0.05. Table 1 , no significant difference between controls and depressed suicide victims was obtained with respect to age. However, the post-mortem delay was significantly longer (6.1 ± 1.1 h) in depressed suicides than in control subjects (3.1 ± 0.81 h; P = 0.027 by Mann-Whitney U-test). GAP-43 protein and PKC isoenzyme levels in human brain regions from control subjects and depressed suicide victims are reported in Table 2 . The levels of GAP-43 protein in selected regions of control brains did not show significant differences (Kruskal-Wallis ANOVA: P = 0.213; F = 1.54). The highest levels were found in prefrontal cortex (BA9) and amygdala, the lowest in substantia nigra. Among the PKC isoenzymes measured, only PKC␣ revealed a significantly heterogenous regional distribution (Kruskal-Wallis ANOVA: P Ͻ 0.05; F = 3.324) with the highest level of expression in prefrontal cortex (BA9) and the lowest in amygdala.
Results

As shown in
The main finding of this study was a significant (P = 0.045 by Mann-Whitney U-test) decrease (by 23%) in GAP-43 protein expression in membrane preparations from prefrontal cortex (BA-9) of brains from depressed suicide victims in comparison to control brains, without any significant alterations in other regions. GAP-43 levels in amygdala were even more decreased (by 44%) but the difference vs controls did not reach statistical significance (P = 0.114 by Mann-Whitney U-test). In contrast, the levels of individual PKC isoenzymes were not significantly different in the prefrontal cortex or any other region of control and suicide brains, although there was a trend toward lower levels of PKC␣ in all but one region ( Table 2) .
To examine whether the observed decrease in the levels of GAP-43 protein in prefrontal cortex and amygdala are associated with decreased synthesis of the protein at transcriptional level, we have determined the GAP-43 mRNA levels in these two regions and in another cortical region (frontopolar cortex, BA10) where no significant changes in GAP-43 protein expression were seen. The results reported in Table 3 show that in the region (prefrontal cortex-BA9) where a decrease in GAP-43 protein was found in depressed suicide brains compared to controls, the GAP-43 mRNA levels, expressed as GAP-43 mRNA/␤-actin mRNA ratio, were also significantly lower (P = 0.015 by Mann-Whitney U-test). Scattergrams comparing individual values of GAP-43 protein and GAP-43 mRNA in the prefrontal cortex (BA9), frontopolar cortex (BA10) and amygdala from brains of controls and depressed suicide victims are presented in Figure 3 . Mean value of mRNA in amygdala was again considerably decreased (by 43%) in depressed suicides but the difference vs controls did not reach a statistical significance (P = 0.074 by Mann-Whitney U-test).
We have examined the relationship between GAP-43 levels and GAP-43 mRNA in prefrontal cortex and amygdala, and the demographic variables (age, postmortem delay) by non-parametric Spearman rank correlation test and found no significant correlation (prefrontal cortex: GAP-43 vs age: P = 0256; = 0.267; vs post-mortem delay: P = 0.386; = −0.205; GAP-43 Table 3 GAP-43 mRNA levels in human brain regions from controls and depressed suicide victims Values are means ± SEM; n, number of subjects. Significance of differences from controls: **P Ͻ 0.015 by Mann-Whitney U test. Although we found no significant correlation between age or post-mortem delay and GAP-43 or its mRNA in prefrontal cortex and amygdala, in view of a significant difference in post-mortem delay between depressed suicides and controls, we have examined the group differences in GAP-43 and its mRNA by ANCOVA with age and post-mortem delay as covariates. The results of the analysis are reported in Table  4 and show that the group differences for GAP-43 and its mRNA in prefrontal cortex remained significant (F = 6.105; P = 0.025 and F = 5.378; P = 0.034, respectively) even after covarying them with age and post-mortem delay.
In the suicide group, there were two subjects diagnosed as bipolar depressives and one as depressive with psychotic features. The individual levels of GAP-43 and its mRNA in these subjects were within 1 s.d. of the group mean except for the GAP-43 level in prefrontal cortex of one bipolar subject and in amygdala of the two bipolar subjects which were higher but were not considered outliers.
Discussion
In human brain, GAP-43 is enriched in associative cortices and limbic system 15 suggesting a potential role of this protein in cognitive and affective functions. The main finding of the present study was a significant decrease in GAP-43 protein levels in prefrontal cortex (BA9), but not in other regions (frontopolar cortex-BA10, amygdala, substantia nigra or putamen) of brain from depressed suicide victims in comparison with control subjects. A corresponding decrease in GAP-43 mRNA levels was also found in samples from pre- frontal cortex (BA9) but not from frontopolar cortex (BA10) or amygdala, suggesting that the synthesis of this protein is decreased in a specific brain region of depressed suicides. This is further supported by a significant correlation found between the abundance of GAP-43 protein and its mRNA in prefrontal cortex of individual brains. GAP-43 is known to be involved in the establishment and reorganization of synaptic connections, 15 a process maintained throughout life in some brain regions. Thus, the perturbation of the synaptic function and neuroplasticity caused by a decrease in GAP-43 expression in the prefrontal cortex may be one of the mechanisms involved in the pathogenesis of depression and suicide.
It has been reported that GAP-43 expression is regulated by some neurotrophic factors and it has been suggested that alterations in neurotrophins, namely the brain-derived neurotrophic factor (BDNF) play a role in the pathophysiology of certain forms of depression. 33 A dramatic reduction of BDNF expression was found in rat brain under immobilization stress. 34 Thus, chronic stress that can precipitate and exacerbate depression may be associated with a decrease of BDNF which, in turn, then may decrease GAP-43 expression in some brain regions. Considering that both GAP-43 protein and its mRNA were decreased in the prefrontal cortex, it is conceivable that local neurons are involved in these changes. However, we cannot exclude that reduced GAP-43 in the axonal projections to this region, eg from monoaminergic neurons, may also contribute to the decreased level of this protein. A similar change might have an influence on the release of monoamines in this region. In fact, there is some evidence showing that reduction of GAP-43 inhibits the release of noradrenaline from cerebrocortical synapto-somes 17 and of dopamine from permeated synaptosomes 18 and P12 cells. 19 Although there are no data with respect to 5-HT release, one can hypothesize a similar involvement of GAP-43 in this monoaminergic system.
It is of interest to note, that virtually all previous studies on brain of suicide victims reported changes in 5-HT 2A , ␣-and ␤-adrenergic or dopaminergic receptor densities in prefrontal cortex (BA9) 1, 2, [4] [5] [6] 35 whereas no changes were reported for BA10. [36] [37] [38] Region-specific changes in brain of depressed suicides were found in other neuronal signalling components, such as stimulation of PI hydrolysis or G ␣i2 expression. 39 Recently, Drevets and colleagues 8 using imaging techniques to measure regional blood flow and glucose metabolism, found a significant reduction in activity in the subgenual prefrontal cortex in familial unipolar or bipolar depressives. They also observed a substantial reduction in cortical volume in this area in depressives compared to controls. Our finding of reduction in GAP-43 expression in prefrontal cortex is in good agreement with these observations. The reason for the regional selectivity is not immediately apparent, since little is known about the functional role or circuitry of cortical Brodmann areas. Nevertheless, the observed changes in GAP-43 expression, 5-HT 2A , adrenergic and dopaminergic receptor density and in the metabolism in prefrontal cortex point to the important role of this cortical area in the pathophysiology of depressive illness and suicide.
Region-selective changes in GAP-43 levels have also been reported in brains of schizophrenics 23 where selective increases in GAP-43 expression were found in visual association and frontal cortices (BA20, BA9 and 10), but not in primary visual cortex (BA17). In contrast, GAP-43 mRNA levels were reported to be significantly lower in dorsolateral prefrontal cortex of schizophrenics. 40 Absence of any significant alterations in levels of PKC isoenzymes in brain regions of depressed suicides is in agreement with a recent study 39 that reported no differences in PKC␣ levels in cortical BA9 and BA10 from depressed suicide brains in comparison to controls. However, the PKC isoenzyme levels in the membrane fraction of brain tissue as determined in this study do not reflect the activity of these enzymes, that still may functionally regulate the serotonergic signalling. Results of other studies with phorbol ester binding to PKC 41 and stimulation of PI hydrolysis 39 suggest that the changes in the PI-PKC signalling system may indeed be present in brain regions of depressed suicide victims.
In conclusion, we have found that GAP-43 protein levels and GAP-43 mRNA expression are significantly decreased in prefrontal cortex (BA9), but not in frontopolar cortex (BA10), amygdala, substantia nigra or putamen from brains of depressed suicide victims in comparison with matched controls. Considering the role of this protein in synaptic reorganization and functional plasticity in the adult central nervous system we argue that this region may be less reactive to plastic changes dependent on neuronal activity.
